News Archive
Date: 04/03/2013
Large, international trial finds intermittent androgen deprivation is not equivalent to continuous treatment of prostate cancer.
Date: 03/20/2013
Samuel M. Silver, MD, PhD, of the University of Michigan Rogel Cancer Center, has been elected Chairman of the National Comprehensive Cancer Network® (NCCN®) Board of Directors.
Date: 03/12/2013
University of Michigan MOHS clinicians have developed a new technique which delivers good cosmetic result without 2nd procedure.
Date: 03/01/2013
University of Michigan researchers have discovered that inhibiting a signaling pathway in some of the transplanted cells could prevent the most serious potential complications of the procedure, a conflict between the transplanted cells and the recipient's own tissue called graft-versus-host disease.
Date: 02/26/2013
Written by Nicole Fawcett
Date: 02/05/2013
Researchers at the University of Michigan Rogel Cancer Center have developed a method that could enhance gene sequencing data.
Date: 01/19/2013
Kathleen Cooney, M.D., have been named deputy director for clinical services at the University of Michigan Rogel Cancer Center.
Date: 01/14/2013
By looking at the entire DNA from a fibrous tumor, University of Michigan Rogel Cancer Center researchers have found a genetic anomaly that provides an important clue to improving how this cancer is diagnosed and treated.
Date: 12/12/2012
Written by: Nicole Casal Moore, 734-647-7087, [email protected] Fawcett, 734-764-2220, [email protected]